A few more snippets and quotes that I thought were impressive from the Qantas MyBusiness interview,
- AK: "do you have the only product that gets through a biofilm". JM: "we do"
- JM: "we're researching in cystic fibrosis for the lungs"
- JM: "sinusitis product this year"
A CEO of the calibre of Judith Mitchell wouldn't make these comments unless she knew they'd deliver on them with results and more announcements.
Also, the financial review interview last year forecasting $20m in sales in 2019 is significant, even though I'd prefer to know customer sales rather than distributor purchases as I expect a few of these deals would have included agreements with guaranteed purchases locked in for 2019.
How the rich invest: Lang Walker backs Next Science's bacteria buster, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.010(4.44%) |
Mkt cap ! $68.54M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $46.14K | 206.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 130676 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 19533 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |